Cancer (Pediatric) Clinical Trials

Savannah : Memorial University Medical Center Updated

AALL0631: A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND #76431; NSC# 617807)

Savannah : Memorial University Medical Center Updated

ABTR01B1: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples from Young Patients with Cancer

Savannah : Memorial University Medical Center Updated

ACCRN07: Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN)

Savannah : Memorial University Medical Center Updated

ACNS0334: A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 months old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue Versus the Same Therapy Without Methotrexate

Savannah : Memorial University Medical Center Updated

ACNS0927: A Phase I/II Study of Suberoylanilide Hydromaxic Acid (SAHA, Vorinostat) and Local Irradiation, Followed by Maintenance SAHA in Children with Newly Diagnosed Diffuse Intrinsic Pontine Gilomas (DIPG)

Savannah : Memorial University Medical Center Updated

AEWS07B1: Collecting and Storing Biological Samples From Patients with Ewing Sarcoma

Savannah : Memorial University Medical Center Updated

ALTE07C1: Neuropsychological and Behavioral Testing in Young Patients with Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)